德益控股(08522.HK)将转往主板上市
格隆汇12月19日丨德益控股(08522.HK)发布公告,2019年7月26日,公司根据主板上市规则第9A章就批准股份以转板上市方式于主板上市及买卖向联交所提出申请。联交所已于2019年12月18日原则上批准转板上市。于该公告日期,与公司及股份有关的所有适用于转板上市的先决条件均已获达成。
股份于GEM的最后交易日将为2019年12月27日。预计股份将于2019年12月30日上午九时正开始于主板( 主板股份代号:9900 )进行买卖。于转板上市后,公司中英文股份简称、现有股票、每手买卖单位、股份交易货币、股份过户登记总处及香港股份过户登记分处均维持不变。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.